KDM4A and cancer: Interestingly, our data also implicate KDM4A in the suppression of HLA expression, which is reminiscent of the loss of heterozygocity in MPM specimen with high tumor burden, further supporting immune evasion mechanisms of the cancer cells (Lapidot et al., 2021; Zhang et al., 2021).